Initial Treatment for Newly Diagnosed Hypertension
For patients with newly diagnosed hypertension, first-line pharmacological therapy should include a thiazide or thiazide-like diuretic, an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), or a dihydropyridine calcium channel blocker (CCB), with the specific choice guided by patient characteristics and comorbidities. 1, 2, 3
Step 1: Lifestyle Modifications
Lifestyle modifications should be prescribed for all patients with hypertension, regardless of whether pharmacological therapy is initiated:
Dietary changes:
Physical activity:
Other modifications:
Step 2: Pharmacological Therapy Decision
When to Start Medications
Stage 1 Hypertension (130-139/80-89 mmHg):
- Start medications if patient has:
- Clinical cardiovascular disease
- Diabetes mellitus
- Chronic kidney disease
- 10-year atherosclerotic cardiovascular disease risk ≥10%
- Otherwise, begin with lifestyle modifications alone and reassess in 3-6 months 1
- Start medications if patient has:
Stage 2 Hypertension (≥140/90 mmHg):
First-Line Medication Selection
Choose from one of these first-line agents based on patient characteristics:
Thiazide or thiazide-like diuretics (e.g., hydrochlorothiazide, chlorthalidone)
- Particularly effective in patients of African descent 2
- Starting dose for hydrochlorothiazide: 12.5-25 mg daily
ACE inhibitors (e.g., lisinopril)
ARBs (e.g., losartan)
Dihydropyridine calcium channel blockers (e.g., amlodipine)
- Particularly effective in patients of African descent 2
- Can be used in pregnancy (nifedipine specifically)
Special Population Considerations
- Coronary artery disease: ACEIs or ARBs recommended as first-line therapy 1
- Chronic kidney disease: ACEIs or ARBs preferred 1
- Diabetes with albuminuria: ACEIs or ARBs preferred 1
- African descent patients: Consider thiazide diuretic or CCB as initial therapy 2
- Pregnancy: Avoid ACEIs and ARBs; methyldopa, labetalol, and nifedipine are preferred 2
Step 3: Monitoring and Follow-up
- Follow up approximately monthly for drug titration until BP is controlled 1
- Check electrolytes and renal function 2-4 weeks after initiating therapy, especially with diuretics, ACEIs, or ARBs 2
- Once BP is controlled, follow up every 3-6 months 2
- Consider home BP monitoring to guide treatment adjustments 2
Treatment Escalation
If BP remains uncontrolled on monotherapy:
- Increase the dose of the initial agent to maximum tolerated dose
- Add a second agent from a different class (typically combining an ACEI/ARB with either a thiazide diuretic or CCB)
- Add a third agent if needed (typically an ACEI/ARB + thiazide diuretic + CCB)
Common Pitfalls to Avoid
- Inadequate dosing: Ensure medications are titrated to effective doses before adding new agents
- Medication non-adherence: Discuss potential side effects and importance of consistent medication use
- Ignoring lifestyle factors: Continuing lifestyle modifications is essential even after starting medications 4
- White coat hypertension: Consider home or ambulatory BP monitoring to confirm diagnosis 1
- Overlooking secondary causes: Consider screening for secondary hypertension in resistant cases 1
By following this algorithmic approach, most patients with newly diagnosed hypertension can achieve adequate blood pressure control, reducing their risk of cardiovascular events and mortality.